assay
>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
form
powder
packaging
pkg of 1 × 1 g (830071P-1g), pkg of 1 × 200 mg (830071P-200mg), pkg of 1 × 25 mg (830071P-25mg), pkg of 1 × 500 mg (830071P-500mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
lipid type
phosphoglycerides
phospholipids
shipped in
dry ice
storage temp.
−20°C
SMILES string
[P](=O)([O-])(OC[C@H](O)COC(=O)CCCCCCCCCCCCCCC)OCC[N+](C)(C)C
InChI
1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1
InChI key
ASWBNKHCZGQVJV-HSZRJFAPSA-N
Application
蛋黄Lyso PC已用于制备脂质体。它还用作液相色谱-质谱（LC-MS）的脂质标准品。
Packaging
20 mL透明玻璃螺旋盖样品瓶（830071P-1g）
20 mL透明玻璃螺旋盖样品瓶（830071P-500mg）
5 mL棕色玻璃螺旋盖样品瓶（830071P-200mg）
5 mL棕色玻璃螺旋盖样品瓶（830071P-25mg）
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
11 - Combustible Solids
Amperometric post spike feet reveal most exocytosis is via extended kiss-and-run fusion
Mellander LJ, et al.
Scientific Reports, 2 (2012)
Amperometric post spike feet reveal most exocytosis is via extended kiss-and-run fusion
Mellander LJ, et al.
Scientific reports, 2 (2012)
Padma Iyer et al.
PloS one, 7(8), e42627-e42627 (2012-08-24)
Primary open-angle glaucoma is the second leading cause of blindness in the United States and is commonly associated with elevated intraocular pressure (IOP) resulting from diminished aqueous humor (AH) drainage through the trabecular pathway. Developing effective therapies for increased IOP
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 830071P-1G | 04061835353385 |
| 830071P-500MG | 04061835353415 |
| 830071P-200MG | 04061835353392 |
| 830071P-25MG | 04061835353408 |